
Checkmate Pharmaceuticals CMPI
Checkmate Pharmaceuticals EV - Enterprise Value | CMPI
Annual EV - Enterprise Value Checkmate Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 11.4 M | 114 M | 1.45 M | 3.32 M | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 114 M | 1.45 M | 32.7 M |
EV - Enterprise Value of other stocks in the Biotechnology industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Regulus Therapeutics
RGLS
|
-30.8 M | - | - | $ 155 M | ||
|
NGM Biopharmaceuticals
NGM
|
91.5 M | - | - | $ 127 M | ||
|
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
4.14 B | $ 84.95 | 0.13 % | $ 7.99 B | ||
|
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | ||
|
Gilead Sciences
GILD
|
176 B | $ 166.01 | -0.31 % | $ 207 B | ||
|
Assembly Biosciences
ASMB
|
301 M | $ 22.14 | -1.6 % | $ 248 M | ||
|
Dynavax Technologies Corporation
DVAX
|
2.02 B | - | - | $ 2.02 B | ||
|
Turning Point Therapeutics
TPTX
|
1.92 B | - | -0.13 % | $ 3.73 B | ||
|
Orgenesis
ORGS
|
38.8 M | - | -33.86 % | $ 61.2 M | ||
|
TCR2 Therapeutics
TCRR
|
92.6 M | - | - | $ 58.1 M | ||
|
ASLAN Pharmaceuticals Limited
ASLN
|
16.7 M | - | -14.27 % | $ 1.7 M | ||
|
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | ||
|
BELLUS Health
BLU
|
1.63 B | - | - | $ 2.47 B | ||
|
Intra-Cellular Therapies
ITCI
|
13.2 B | - | - | $ 13.6 B | ||
|
Marinus Pharmaceuticals
MRNS
|
530 M | - | - | $ 29.6 M | ||
|
GeoVax Labs
GOVX
|
242 M | $ 1.83 | -4.45 % | $ 8.35 M | ||
|
Unity Biotechnology
UBX
|
51.7 M | - | -33.41 % | $ 3.37 M | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
Tyme Technologies
TYME
|
-5.81 M | - | 8.07 % | $ 54 M | ||
|
Karuna Therapeutics
KRTX
|
11.7 B | - | - | $ 12.2 B | ||
|
Corner Growth Acquisition Corp.
COOL
|
109 M | - | -0.89 % | $ 114 M | ||
|
Revance Therapeutics
RVNC
|
972 M | - | - | $ 309 M | ||
|
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | ||
|
TRACON Pharmaceuticals
TCON
|
-2.67 M | - | -1.38 % | $ 46.8 M | ||
|
Forward Pharma A/S
FWP
|
513 M | - | -0.75 % | $ 18.7 M | ||
|
9 Meters Biopharma
NMTR
|
35.6 M | - | -42.97 % | $ 1.05 M | ||
|
Theratechnologies
THTX
|
139 M | - | - | $ 83.9 M | ||
|
Allena Pharmaceuticals
ALNA
|
11.9 M | - | 3.16 % | $ 1.9 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
143 M | - | -15.15 % | $ 60.3 M | ||
|
TFF Pharmaceuticals
TFFP
|
7.83 M | - | -60.05 % | $ 125 K | ||
|
Codiak BioSciences
CDAK
|
284 M | - | -55.98 % | $ 2.15 M | ||
|
Sage Therapeutics
SAGE
|
436 M | - | - | $ 527 M | ||
|
Paratek Pharmaceuticals
PRTK
|
390 M | - | - | $ 121 M | ||
|
AVEO Pharmaceuticals
AVEO
|
111 M | - | - | $ 521 M | ||
|
Cyclerion Therapeutics
CYCN
|
10.1 M | $ 34.99 | 3.77 % | $ 147 M | ||
|
Seelos Therapeutics
SEEL
|
41.4 M | - | -47.76 % | $ 6.27 M | ||
|
Завод ДИОД
DIOD
|
3.14 B | - | - | - | ||
|
Kiromic BioPharma
KRBP
|
24.8 M | - | 6.61 % | $ 3.08 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
1.24 B | - | - | $ 2.18 B | ||
|
Fusion Pharmaceuticals
FUSN
|
1.39 B | - | - | $ 1.41 B | ||
|
Gritstone Oncology
GRTS
|
339 M | - | 0.42 % | $ 213 M | ||
|
Aridis Pharmaceuticals
ARDS
|
38.2 M | - | 17.91 % | $ 11.1 M | ||
|
Titan Pharmaceuticals
TTNP
|
-2.35 M | - | -3.76 % | $ 3.47 M | ||
|
HOOKIPA Pharma
HOOK
|
-8.35 M | - | -6.92 % | $ 79.4 M | ||
|
Otonomy
OTIC
|
90.8 M | - | -1.96 % | $ 4.68 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
2.33 B | $ 286.96 | 0.01 % | $ 5.55 B | ||
|
Фармсинтез
LIFE
|
59.3 B | - | - | - | ||
|
Actinium Pharmaceuticals
ATNM
|
26.8 M | $ 1.04 | -4.59 % | $ 32.4 M |